Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 252

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

A role for heme in Alzheimer's disease: Heme binds amyloid β and has altered metabolism

Open access
Atamna, Hani, Frey, William H.·2004·Proceedings of the National Academy of Sciences

Abstract

Heme is a common factor linking several metabolic perturbations in Alzheimer's disease (AD), including iron metabolism, mitochondrial complex IV, heme oxygenase, and bilirubin. Therefore, we determined whether heme metabolism was altered in temporal lobes obtained at autopsy from AD patients and age-matched nondemented subjects. AD brain demonstrated 2.5-fold more heme- b ( P < 0.01) and 26% less heme- a ( P = 0.16) compared with controls, resulting in a highly significant 2.9-fold decrease in heme- a /heme- b ratio ( P < 0.001). Moreover, the strong Pearson correlation between heme- a and heme- b measured in control individuals ( r 2 = 0.66, P < 0.002, n = 11) was abolished in AD subjects ( r 2 = 0.076, P = 0.39, n = 12). The level of ferrochelatase (which makes heme- b in the mitochondrial matrix) in AD subjects was 4.2 times ( P < 0.04) that in nondemented controls, suggesting up-regulated heme synthesis. To look for a possible connection between these observations and established mechanisms in AD pathology, we examined possible interactions between amyloid β (Aβ) and heme. Aβ (1–40) and Aβ (1–42) induced a redshift of 15–20 nm in the spectrum of heme- b and heme- a , suggesting that heme binds Aβ, likely to one or more of the histidine residues. Lastly, in a tissue culture model, we found that clioquinol, a metal chelator in clinical trials for AD therapy, decreased intracellular heme. In light of these observations, we have proposed a model of AD pathobiology in which intracellular Aβ complexes with free heme, thereby decreasing its bioavailability (e.g., heme- a ) and resulting in functional heme deficiency. The model integrates disparate observations, including Aβ, mitochondrial dysfunction, cholesterol, and the proposed efficacy of clioquinol.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0404349101

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 252

Metadata

Authors
Atamna, H., & Frey, W. H.
Venue
Proceedings of the National Academy of Sciences
Published
2004-07-19
Volume
101
Issue
30
Pages
11153-11158
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2127960694
Cited by
252
References
9
FWCI
4.94
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A role for heme in Alzheimer's disease: Heme binds amyloid β and has altered metabolism. https://app.cochat.ai/papers/10.1073/pnas.0404349101
The paper
Atamna, H., & Frey, W. H. (2004). A role for heme in Alzheimer's disease: Heme binds amyloid β and has altered metabolism. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0404349101

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.